Financials

  • Market Capitalization 157.6336 M
  • Employee 184
  • Founded 2004
  • CEO Laura Niklason
  • Website www.humacyte.com
  • Headquarter Delaware, United States
  • FIGI BBG00XPPT7S7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.36
Relación precio/flujo de caja
7.27

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
7152
SABSW
SAB Biotherapeutics, Inc. - Warrant
0.0150 USD+20.00%-37.50%+13.64%-70.00%275.27 M USD
7180
SRZNW
Surrozen, Inc. - Warrant
0.0128 USD0.00%+33.33%-23.81%-28.49%254.03 M USD
7275
YDESW
YD Bio Limited - Warrants
0.2600 USD+1.52%-21.26%-18.75%-52.73%150.07 M USD
7284
FBIOP
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
18.75 USD+0.27%-5.73%-10.71%+134.38%136.69 M USD